Shareholding disclosure

Kuros Biosciences AG

Collectively declared rate

Threshold

Fell below threshold

Timeline

Published

23.01.2016

Transaction

22.01.2016

Voting rights breakdown

Voting rights acquired0%

Voting rights sold0%

Below threshold3%

Declared beneficial owners · 2

A single, collectively filed disclosure: the voting-rights rate applies to the whole group, not to each person.

Notice details

CategoryGroup of shareholders

ExchangeXSWX

Notification ID

TBG1M00040

Beneficial owner

Abingworth LLP

Declared address

Abingworth LLP, London

Open shareholder profile Open company profile

Back to the feed

Shareholding disclosure

Kuros Biosciences AG

Kuros Biosciences AG23.01.2016TBG1M00040

Disclosure summary

Abingworth LLP disclosed a holding in Kuros Biosciences AG that fell below the publication threshold, published by SIX Exchange Regulation on 23.01.2016, at 3% of voting rights. The filing groups 2 beneficial owners declared together. Notice category: Group of shareholders.

Disclosed position

Collectively declared rate

2 people

Below threshold

Voting rights acquired0%

Voting rights sold0%

Below threshold3%

Never miss a market signal again

Create a free account

Need more? Discover the Pro plan

Pro alertsEmail and Telegram after publication

Unlimited company trackingUnlimited watchlist with the Pro plan

Monday recapYour stocks' essentials at the open

Declared beneficial owners · 2 people

A single, collectively filed disclosure: the voting-rights rate applies to the whole group, not to each person.

Disclosure detail

Abingworth LLP disclosed a holding in Kuros Biosciences AG, published on 23.01.2016.

Publication date23.01.2016

Transaction date22.01.2016

Issuing companyKuros Biosciences AG

Beneficial ownerAbingworth LLP

Declared addressAbingworth LLP, London

CategoryGroup of shareholders

Voting rights acquired0%

Voting rights sold0%

Below threshold3%

ExchangeXSWX

Notification IDTBG1M00040

Source: SIX Exchange Regulation · Publication date: 23.01.2016

These figures aggregate public disclosures. They are not investment advice.

insider24.ch

Never miss a market signal again

Create a free account

Need more? Discover the Pro plan

Pro alertsEmail and Telegram after publication

Unlimited company trackingUnlimited watchlist with the Pro plan

Monday recapYour stocks' essentials at the open